DUSP1 levels are also diminished in cortical tissues obtained from AD patients and correlate with tau pathology, cognitive decline, and high blood levels of glucocorticoids; the latter represents a risk factor for AD. The gene discussed is MAPT; the disease is Alzheimer disease.